Susan L. Kelley - Net Worth and Insider Trading

Susan L. Kelley Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Susan L. Kelley owns 5 companies in total, including Deciphera Pharmaceuticals Inc (DCPH) , Dare Bioscience Inc (DARE) , and Arqule Inc (ARQL) among others .

Click here to see the complete history of Susan L. Kelley’s form 4 insider trades.

Insider Ownership Summary of Susan L. Kelley

Ticker	Comapny	Transaction Date	Type of Owner
DCPH	Deciphera Pharmaceuticals Inc	2019-07-08	director
DARE	Dare Bioscience Inc	2014-10-03	director
ARQL	Arqule Inc	2020-01-16	director
IMDZ	Immune Design Corp	2019-04-02	director
IDYA	IDEAYA Biosciences Inc	2021-02-12	director

Susan L. Kelley Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Susan L. Kelley Ownership Network

Ownership Network List of Susan L. Kelley

No Data

Ownership Network Relation of Susan L. Kelley

Susan L. Kelley Owned Company Details

What does Deciphera Pharmaceuticals Inc do?

Who are the key executives at Deciphera Pharmaceuticals Inc?

Susan L. Kelley is the director of Deciphera Pharmaceuticals Inc. Other key executives at Deciphera Pharmaceuticals Inc include SVP & Regulatory & Quality Jama Pitman , Chief Commercial Officer Daniel C. Martin , and Chief Financial Officer Thomas Patrick Kelly .

Deciphera Pharmaceuticals Inc (DCPH) Insider Trades Summary

Over the past 18 months, Susan L. Kelley made no insider transaction in Deciphera Pharmaceuticals Inc (DCPH). Other recent insider transactions involving Deciphera Pharmaceuticals Inc (DCPH) include a net sale of 26,559 shares made by Daniel C. Martin , a net sale of 14,587 shares made by Matthew L Sherman , and a net sale of 11,601 shares made by Thomas Patrick Kelly .

In summary, during the past 3 months, insiders sold 0 shares of Deciphera Pharmaceuticals Inc (DCPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 154,121 shares of Deciphera Pharmaceuticals Inc (DCPH) were sold and 1,687,666 shares were bought by its insiders, resulting in a net purchase of 1,533,545 shares.

Deciphera Pharmaceuticals Inc (DCPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

Deciphera Pharmaceuticals Inc Insider Transactions

No Available Data

What does Dare Bioscience Inc do?

Who are the key executives at Dare Bioscience Inc?

Susan L. Kelley is the director of Dare Bioscience Inc. Other key executives at Dare Bioscience Inc include director & Chef Executive Officer Sabrina Martucci Johnson , Chief Strategy Officer John A Fair , and Chief Financial Officer Lisa Walters-hoffert .

Dare Bioscience Inc (DARE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Dare Bioscience Inc (DARE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dare Bioscience Inc (DARE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Dare Bioscience Inc (DARE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Dare Bioscience Inc Insider Transactions

No Available Data

What does Arqule Inc do?

Who are the key executives at Arqule Inc?

Susan L. Kelley is the director of Arqule Inc. Other key executives at Arqule Inc include director & Chief Executive Officer Paolo Pucci , CFO and Treasurer Marc Schegerin , and See Remarks Brian Schwartz .

Arqule Inc (ARQL) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Arqule Inc (ARQL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Arqule Inc (ARQL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Arqule Inc (ARQL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Arqule Inc Insider Transactions

No Available Data

What does Immune Design Corp do?

Who are the key executives at Immune Design Corp?

Susan L. Kelley is the director of Immune Design Corp. Other key executives at Immune Design Corp include 10 percent owner & other: General Partner Column Group Gp, Lp , 10 percent owner Column Group L P , and 10 percent owner & other: General Partner Ponoi Management, Llc .

Immune Design Corp (IMDZ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Immune Design Corp (IMDZ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immune Design Corp (IMDZ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Immune Design Corp (IMDZ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Immune Design Corp Insider Transactions

No Available Data

What does IDEAYA Biosciences Inc do?

Who are the key executives at IDEAYA Biosciences Inc?

Susan L. Kelley is the director of IDEAYA Biosciences Inc. Other key executives at IDEAYA Biosciences Inc include See Remarks Briseno Andres Ruiz , director & President and CEO Yujiro S Hata , and VP & General Counsel Jason Throne .

IDEAYA Biosciences Inc (IDYA) Insider Trades Summary

Over the past 18 months, Susan L. Kelley made no insider transaction in IDEAYA Biosciences Inc (IDYA). Other recent insider transactions involving IDEAYA Biosciences Inc (IDYA) include a net sale of 38,970 shares made by Jason Throne , a net sale of 10,000 shares made by Briseno Andres Ruiz , and a net sale of 250,000 shares made by Yujiro S Hata .

In summary, during the past 3 months, insiders sold 104,000 shares of IDEAYA Biosciences Inc (IDYA) in total and bought 0 shares, with a net sale of 104,000 shares. During the past 18 months, 311,470 shares of IDEAYA Biosciences Inc (IDYA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 311,470 shares.

IDEAYA Biosciences Inc (IDYA)'s detailed insider trading history can be found in Insider Trading Tracker table.

IDEAYA Biosciences Inc Insider Transactions

No Available Data

Susan L. Kelley Mailing Address

Above is the net worth, insider trading, and ownership report for Susan L. Kelley. You might contact Susan L. Kelley via mailing address: C/o Deciphera Pharmaceuticals, Inc., 200 Smith Street, Waltham Ma 02451.

Discussions on Susan L. Kelley

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Data is updated daily.